GRTX Smart Money
Galera Therapeutics, Inc.
1W: +16.6%
1M: +7.8%
3M: -6.9%
YTD: +313.7%
1Y: +279.8%
3Y: -96.5%
5Y: -99.0%
$17.15
Last traded 2026-08-03 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
👔 Insider Trades
12 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-03 | FRIEDMAN MICHAEL R. | director | D-Sale to Issuer | 41,631 | $— | $0 | Filing |
| 2026-08-03 | Sorensen Mel | officer: president and ceo | D-Sale to Issuer | 975 | $— | $0 | Filing |
| 2026-08-03 | Alleva Lawrence M | director | D-Sale to Issuer | 11 | $— | $0 | Filing |
| 2026-08-03 | Alleva Lawrence M | director | D-Sale to Issuer | 40 | $— | $0 | Filing |
| 2026-08-03 | CHANG NANCY T | director | D-Sale to Issuer | 47,434 | $— | $0 | Filing |
| 2026-05-15 | Emerald Bioventures, LLC | 10% owner | C-Conversion | 20,813,818 | $— | $0 | Filing |
| 2026-05-15 | Opler Timothy | 10% owner | C-Conversion | 20,813,818 | $— | $0 | Filing |
| 2026-05-15 | FRIEDMAN MICHAEL R. | director | C-Conversion | 2,989,399 | $— | $0 | Filing |
| 2026-05-15 | CHANG NANCY T | director | C-Conversion | 661,309 | $— | $0 | Filing |
| 2026-04-07 | FRIEDMAN MICHAEL R. | director | C-Conversion | 5,336,870 | $— | $0 | Filing |
| 2026-04-07 | CHANG NANCY T | director | C-Conversion | 1,180,611 | $— | $0 | Filing |
| 2025-11-20 | Sorensen Mel | officer: president and ceo | S-Sale | 70,000 | $0.02 | $1K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
0 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| No institutional holdings found | |||||